RATIONALE: Behavioural sensitization is a long lasting phenomenon that has been proposed to be involved in drug addiction. Although the expression of cocaine-induced sensitization has been associated with the activity of the mesencephalic dopaminergic neurons, little is known about the transcriptional adaptations of these neurons to a new challenge with cocaine long after cessation of repeated exposure to the drug. OBJECTIVES: We studied the time course of the mRNA levels of three main regulatory elements of dopaminergic transmission after a challenge with cocaine (15 mg/kg) that followed 21 days of withdrawal from a cocaine pretreatment (20 mg/kg, ip, every 2 days for 21 days) in C57Bl/6J mice. MATERIALS AND METHODS: Mice were placed 45 min in activity chambers and were killed 45 min, 2 h or 24 h after the challenge injection. Dopamine transporter (DAT), D2 auto-receptor (D2) and tyrosine hydroxylase (TH) mRNA levels were assessed by in situ hybridization in the ventral tegmental area and the substantia nigra compacta. RESULTS: As compared to vehicle challenge, cocaine challenge in vehicle pretreated mice induced a rapid increase (+208%) in DAT mRNA (45 min) followed by a delayed decrease (-70%) (24 h), while TH and D2 mRNA were both increased (+45%) 24 h after the challenge. In cocaine pretreated mice, cocaine-induced short-term increase and long-term decrease in DAT mRNA levels were amplified (+328%) and reduced (-40%), respectively. CONCLUSIONS: Repeated exposure to cocaine alters the transcriptional response of DA neurons to a new cocaine challenge long after cessation of repeated exposure to the drug. They point to the DAT mRNA as a major responsive element to a new presentation of cocaine.
RATIONALE: Behavioural sensitization is a long lasting phenomenon that has been proposed to be involved in drug addiction. Although the expression of cocaine-induced sensitization has been associated with the activity of the mesencephalic dopaminergic neurons, little is known about the transcriptional adaptations of these neurons to a new challenge with cocaine long after cessation of repeated exposure to the drug. OBJECTIVES: We studied the time course of the mRNA levels of three main regulatory elements of dopaminergic transmission after a challenge with cocaine (15 mg/kg) that followed 21 days of withdrawal from a cocaine pretreatment (20 mg/kg, ip, every 2 days for 21 days) in C57Bl/6J mice. MATERIALS AND METHODS: Mice were placed 45 min in activity chambers and were killed 45 min, 2 h or 24 h after the challenge injection. Dopamine transporter (DAT), D2 auto-receptor (D2) and tyrosine hydroxylase (TH) mRNA levels were assessed by in situ hybridization in the ventral tegmental area and the substantia nigra compacta. RESULTS: As compared to vehicle challenge, cocaine challenge in vehicle pretreated mice induced a rapid increase (+208%) in DAT mRNA (45 min) followed by a delayed decrease (-70%) (24 h), while TH and D2 mRNA were both increased (+45%) 24 h after the challenge. In cocaine pretreated mice, cocaine-induced short-term increase and long-term decrease in DAT mRNA levels were amplified (+328%) and reduced (-40%), respectively. CONCLUSIONS: Repeated exposure to cocaine alters the transcriptional response of DA neurons to a new cocaine challenge long after cessation of repeated exposure to the drug. They point to the DAT mRNA as a major responsive element to a new presentation of cocaine.
Authors: Lynette C Daws; Paul D Callaghan; José A Morón; Kris M Kahlig; Toni S Shippenberg; Jonathan A Javitch; Aurelio Galli Journal: Biochem Biophys Res Commun Date: 2002-02-08 Impact factor: 3.575
Authors: L J Vanderschuren; E D Schmidt; T J De Vries; C A Van Moorsel; F J Tilders; A N Schoffelmeer Journal: J Neurosci Date: 1999-11-01 Impact factor: 6.167
Authors: J M Wilson; J N Nobrega; M E Carroll; H B Niznik; K Shannak; S T Lac; Z B Pristupa; L M Dixon; S J Kish Journal: J Neurosci Date: 1994-05 Impact factor: 6.167
Authors: Suzanne O Nolan; Jennifer E Zachry; Amy R Johnson; Lillian J Brady; Cody A Siciliano; Erin S Calipari Journal: J Neurochem Date: 2020-06-19 Impact factor: 5.372
Authors: M C Arenas; A Mateos-García; C Manzanedo; M Rodríguez-Arias; M A Aguilar; F Navarrete; M S García Gutiérrez; J Manzanares; J Miñarro Journal: Psychopharmacology (Berl) Date: 2016-09-05 Impact factor: 4.530
Authors: Lucy G Chastain; Hongyan Qu; Chase H Bourke; P Michael Iuvone; Paul R Dobner; Charles B Nemeroff; Becky Kinkead Journal: Behav Brain Res Date: 2014-11-15 Impact factor: 3.332
Authors: Frederick A Schroeder; Krista L Penta; Anouch Matevossian; Sara R Jones; Christine Konradi; Andrew R Tapper; Schahram Akbarian Journal: Neuropsychopharmacology Date: 2008-02-20 Impact factor: 7.853
Authors: Derek P DiRocco; Zachary S Scheiner; Carlos Balet Sindreu; Guy C-K Chan; Daniel R Storm Journal: J Neurosci Date: 2009-02-25 Impact factor: 6.167
Authors: Nicholas W Simon; Blanca S Beas; Karienn S Montgomery; Rebecca P Haberman; Jennifer L Bizon; Barry Setlow Journal: Eur J Neurosci Date: 2013-03-20 Impact factor: 3.386